What's Next for Immunotherapy in Locally Advanced NSCLC?

被引：0
|
作者：
Ready, Neal Edward [1 ]
机构：
[1] Duke Univ, Med Ctr, Med, Durham, NC 27706 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 05期
关键词：
CELL LUNG-CANCER; ATEZOLIZUMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：302 / 304
页数：3
相关论文
共 50 条
  • [41] Immunotherapy for locally advanced andmetastasized bladder cancer
    Loidl, W.
    Luger, F.
    [J]. UROLOGE, 2018, 57 (11): : 1334 - 1341
  • [42] Improved Patient and Regimen Selection in Locally Advanced Rectal Cancer: Who, How, and What Next?
    Weiss, Jared
    Moghanaki, Drew
    Plastaras, John P.
    Haller, Daniel G.
    [J]. CLINICAL COLORECTAL CANCER, 2009, 8 (04) : 194 - 199
  • [43] What is the meaning of local-regional control after chemoradiation for locally advanced NSCLC? An RTOG analysis
    Machtay, M
    Swann, S
    Komaki, R
    Byhardt, R
    Paulus, R
    Sause, W
    Curran, W
    Albain, K
    Movas, B
    [J]. LUNG CANCER, 2005, 49 : S17 - S17
  • [44] DART-bid with VMAT for locally advanced NSCLC
    Pinter, R.
    Wurstbauer, K.
    Kazil, M.
    Meinschad, M.
    Cerkl, P.
    Kuenzler, T.
    Clemens, P.
    De Vries, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S749 - S749
  • [45] State of the art in definitive treatment of locally advanced NSCLC
    Faivre-Finn, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1 - S2
  • [46] Is Hypofractionation a Good Idea in Radiotherapy for Locally Advanced NSCLC?
    Putora, Paul Martin
    De Ruysscher, Dirk K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (04) : 487 - 488
  • [47] Proton Therapy not superior to IMRT in locally advanced NSCLC
    Dutz, Almut
    Troost, Esther G. C.
    Lock, Steffen
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (08) : 790 - 793
  • [48] The Role of Consolidation Treatment in Locally Advanced Unresectable NSCLC
    Farhad Fakhrejahani
    Nooshin Hashemi Sadraei
    Tarek Mekhail
    [J]. Current Oncology Reports, 2013, 15 : 424 - 432
  • [49] Sequential chemoradiotherapy followed by sugemalimab for locally advanced NSCLC
    Bi, Nan
    Wang, Yu
    Wang, Luhua
    [J]. LANCET ONCOLOGY, 2022, 23 (04): : E158 - E158
  • [50] The Role of Consolidation Treatment in Locally Advanced Unresectable NSCLC
    Fakhrejahani, Farhad
    Sadraei, Nooshin Hashemi
    Mekhail, Tarek
    [J]. CURRENT ONCOLOGY REPORTS, 2013, 15 (04) : 424 - 432
12345